{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:26Z","timestamp":1792788146961,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"name":"Ministry of Health of the Czech Republic","award":["NU21-05-00322"],"award-info":[{"award-number":["NU21-05-00322"]}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Ministry of Education Youth and Sports of the Czech Republic","award":["SVV 260638"],"award-info":[{"award-number":["SVV 260638"]}],"id":[{"id":"https:\/\/ror.org\/037n8p820","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]},{"name":"The large research infrastructure project BBMRI.cz","award":["LM2023033"],"award-info":[{"award-number":["LM2023033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03847-1","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:34:57Z","timestamp":1783006497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alterations in systemic and skeletal muscle myostatin regulation are most prominent at disease onset and associate with muscle-related outcomes in idiopathic inflammatory myopathies"],"prefix":"10.1186","volume":"28","author":[{"given":"Lucia","family":"Vernerov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"L\u00e1\u017enovsk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Baloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Balounov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vokurkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zden\u011bk","family":"Verner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Ki\u010dura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sab\u00edna","family":"Oresk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Svobodov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Krop\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Tom\u010d\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Ukropec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ukropcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"3847_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.12524","volume":"280","author":"IE Lundberg","year":"2016","unstructured":"Lundberg IE, Miller FW, Tjarnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016;280:39\u201351. https:\/\/doi.org\/10.1111\/joim.12524.","journal-title":"J Intern Med"},{"key":"3847_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2796.2010.02334.x","volume":"269","author":"I Loell","year":"2011","unstructured":"Loell I, Lundberg IE. Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies? J Intern Med. 2011;269:243\u201357. https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02334.x.","journal-title":"J Intern Med"},{"key":"3847_CR3","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, Thapliyal R, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005;52:1824\u201335. https:\/\/doi.org\/10.1002\/art.21103.","journal-title":"Arthritis Rheum"},{"key":"3847_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-016-0308-5","volume":"4","author":"C Preu\u00dfe","year":"2016","unstructured":"Preu\u00dfe C, Allenbach Y, Hoffmann O, Goebel H-H, Pehl D, Radke J, et al. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis. Acta Neuropathol Commun. 2016;4:45. https:\/\/doi.org\/10.1186\/s40478-016-0308-5.","journal-title":"Acta Neuropathol Commun"},{"key":"3847_CR5","doi-asserted-by":"publisher","first-page":"103817","DOI":"10.1016\/j.autrev.2025.103817","volume":"24","author":"AS Kamalanathan","year":"2025","unstructured":"Kamalanathan AS, Agarwal V, Talamini L, Muller S. Autophagy in myositis, a dysregulated pathway, and a target for therapy. Autoimmun Rev. 2025;24:103817. https:\/\/doi.org\/10.1016\/j.autrev.2025.103817.","journal-title":"Autoimmun Rev"},{"key":"3847_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13075-016-1033-y","volume":"18","author":"I Loell","year":"2016","unstructured":"Loell I, Raouf J, Chen Y-W, Shi R, Nennesmo I, Alexanderson H, et al. Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Res Ther. 2016;18:136. https:\/\/doi.org\/10.1186\/s13075-016-1033-y.","journal-title":"Arthritis Res Ther"},{"key":"3847_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1152\/japplphysiol.00874.2015","volume":"120","author":"Y-S Lee","year":"2016","unstructured":"Lee Y-S, Huynh TV, Lee S-J. Paracrine and endocrine modes of myostatin action. J Appl Physiol (1985). 2016;120:592\u20138. https:\/\/doi.org\/10.1152\/japplphysiol.00874.2015.","journal-title":"J Appl Physiol (1985)"},{"key":"3847_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcp.20757","volume":"209","author":"C McFarlane","year":"2006","unstructured":"McFarlane C, Plummer E, Thomas M, Hennebry A, Ashby M, Ling N, et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol. 2006;209:501\u201314. https:\/\/doi.org\/10.1002\/jcp.20757.","journal-title":"J Cell Physiol"},{"key":"3847_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1210\/en.2008-0959","volume":"150","author":"A Amirouche","year":"2009","unstructured":"Amirouche A, Durieux A-C, Banzet S, Koulmann N, Bonnefoy R, Mouret C, et al. Down-regulation of Akt\/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology. 2009;150:286\u201394. https:\/\/doi.org\/10.1210\/en.2008-0959.","journal-title":"Endocrinology"},{"key":"3847_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori R, Romanello V, Sandri M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat Commun. 2021;12:330. https:\/\/doi.org\/10.1038\/s41467-020-20123-1.","journal-title":"Nat Commun"},{"key":"3847_CR11","doi-asserted-by":"publisher","first-page":"40735","DOI":"10.1074\/jbc.M206379200","volume":"277","author":"JJ Hill","year":"2002","unstructured":"Hill JJ, Davies MV, Pearson AA, Wang JH, Hewick RM, Wolfman NM, et al. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J Biol Chem. 2002;277:40735\u201341. https:\/\/doi.org\/10.1074\/jbc.M206379200.","journal-title":"J Biol Chem"},{"key":"3847_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13395-018-0180-z","volume":"8","author":"A Iskenderian","year":"2018","unstructured":"Iskenderian A, Liu N, Deng Q, Huang Y, Shen C, Palmieri K, et al. Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone. Skelet Muscle. 2018;8:34. https:\/\/doi.org\/10.1186\/s13395-018-0180-z.","journal-title":"Skelet Muscle"},{"key":"3847_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ymthe.2017.02.015","volume":"25","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Sahenk Z, Al-Zaidy S, Rodino-Klapac LR, Lowes LP, Alfano LN, et al. Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes. Mol Ther. 2017;25:870\u20139. https:\/\/doi.org\/10.1016\/j.ymthe.2017.02.015.","journal-title":"Mol Ther"},{"key":"3847_CR14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1038\/s41467-017-01486-4","volume":"8","author":"V Mariot","year":"2017","unstructured":"Mariot V, Joubert R, Hourd\u00e9 C, F\u00e9asson L, Hanna M, Muntoni F, et al. Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. Nat Commun. 2017;8:1859. https:\/\/doi.org\/10.1038\/s41467-017-01486-4.","journal-title":"Nat Commun"},{"key":"3847_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez651","author":"L Vernerov\u00e1","year":"2020","unstructured":"Vernerov\u00e1 L, Horv\u00e1thov\u00e1 V, Krop\u00e1\u010dkov\u00e1 T, Vokurkov\u00e1 M, Klein M, Tom\u010d\u00edk M, et al. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies. Rheumatology (Oxford). 2020. https:\/\/doi.org\/10.1093\/rheumatology\/kez651.","journal-title":"Rheumatology (Oxford)"},{"key":"3847_CR16","doi-asserted-by":"publisher","first-page":"e12849","DOI":"10.1111\/nan.12849","volume":"49","author":"A Mahoudeau","year":"2023","unstructured":"Mahoudeau A, Anquetil C, Tawara N, Khademian H, Amelin D, Bolko L, et al. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity. Neuropathol Appl Neurobiol. 2023;49:e12849. https:\/\/doi.org\/10.1111\/nan.12849.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3847_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cytogfr.2009.02.007","volume":"20","author":"DJ Phillips","year":"2009","unstructured":"Phillips DJ, de Kretser DM, Hedger MP. Activin and related proteins in inflammation: not just interested bystanders. Cytokine Growth Factor Rev. 2009;20:153\u201364. https:\/\/doi.org\/10.1016\/j.cytogfr.2009.02.007.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3847_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/me.2010-0127","volume":"24","author":"S-J Lee","year":"2010","unstructured":"Lee S-J, Lee Y-S, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, et al. Regulation of muscle mass by follistatin and activins. Mol Endocrinol. 2010;24:1998\u20132008. https:\/\/doi.org\/10.1210\/me.2010-0127.","journal-title":"Mol Endocrinol"},{"key":"3847_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cytogfr.2013.03.003","volume":"24","author":"MP Hedger","year":"2013","unstructured":"Hedger MP, de Kretser DM. The activins and their binding protein, follistatin-Diagnostic and therapeutic targets in inflammatory disease and fibrosis. Cytokine Growth Factor Rev. 2013;24:285\u201395. https:\/\/doi.org\/10.1016\/j.cytogfr.2013.03.003.","journal-title":"Cytokine Growth Factor Rev"},{"key":"3847_CR20","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1210\/endo.141.5.7531","volume":"141","author":"KL Jones","year":"2000","unstructured":"Jones KL, Brauman JN, Groome NP, de Kretser DM, Phillips DJ. Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin. Endocrinology. 2000;141:1905\u20138. https:\/\/doi.org\/10.1210\/endo.141.5.7531.","journal-title":"Endocrinology"},{"key":"3847_CR21","doi-asserted-by":"publisher","first-page":"16239","DOI":"10.1073\/pnas.0705971104","volume":"104","author":"KL Jones","year":"2007","unstructured":"Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, de Kretser DM, et al. Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A. 2007;104:16239\u201344. https:\/\/doi.org\/10.1073\/pnas.0705971104.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3847_CR22","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1038\/sj.onc.1204720","volume":"20","author":"L Bartholin","year":"2001","unstructured":"Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Bertrand S, et al. FLRG, an activin-binding protein, is a new target of TGFbeta transcription activation through Smad proteins. Oncogene. 2001;20:5409\u201319. https:\/\/doi.org\/10.1038\/sj.onc.1204720.","journal-title":"Oncogene"},{"key":"3847_CR23","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/oby.2011.97","volume":"19","author":"ML Brown","year":"2011","unstructured":"Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, et al. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obes (Silver Spring). 2011;19:1940\u20139. https:\/\/doi.org\/10.1038\/oby.2011.97.","journal-title":"Obes (Silver Spring)"},{"key":"3847_CR24","doi-asserted-by":"publisher","first-page":"40788","DOI":"10.1074\/jbc.M006114200","volume":"275","author":"K Tsuchida","year":"2000","unstructured":"Tsuchida K, Arai KY, Kuramoto Y, Yamakawa N, Hasegawa Y, Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J Biol Chem. 2000;275:40788\u201396. https:\/\/doi.org\/10.1074\/jbc.M006114200.","journal-title":"J Biol Chem"},{"key":"3847_CR25","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76:1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.","journal-title":"Ann Rheum Dis"},{"key":"3847_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","volume":"28","author":"Y Allenbach","year":"2018","unstructured":"Allenbach Y, Mammen AL, Benveniste O, Stenzel W, Immune-Mediated Necrotizing Myopathies Working G. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14\u201316 October 2016. Neuromuscul Disord. 2018;28:87\u201399. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.016.","journal-title":"Neuromuscul Disord"},{"key":"3847_CR27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35. years? Chest. 2010;138:1464\u201374. https:\/\/doi.org\/10.1378\/chest.10-0180.","journal-title":"years? Chest"},{"key":"3847_CR28","first-page":"41","volume-title":"Mixed connective tissue disease and antinuclear antibodies","author":"R Kasukawa","year":"1987","unstructured":"Kasukawa R, Tojo T, Miyawaki S, Yoshida H, Tanimoto K, Nobunaga M, et al. Preliminary Diagnostic Criteria for Classification of Mixed Connective Tissue Disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier Science; 1987. pp. 41\u20137."},{"key":"3847_CR29","first-page":"328","volume":"16","author":"D Alarc\u00f3n-Segovia","year":"1989","unstructured":"Alarc\u00f3n-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol. 1989;16:328\u201334.","journal-title":"J Rheumatol"},{"key":"3847_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford). 2004;43:49\u201354. https:\/\/doi.org\/10.1093\/rheumatology\/keg427.","journal-title":"Rheumatology (Oxford)"},{"key":"3847_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/art.21715","volume":"55","author":"H Alexanderson","year":"2006","unstructured":"Alexanderson H, Broman L, Tollb\u00e4ck A, Josefson A, Lundberg IE, Stenstr\u00f6m CH. Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2006;55:114\u201322. https:\/\/doi.org\/10.1002\/art.21715.","journal-title":"Arthritis Rheum"},{"key":"3847_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-5-54","volume":"5","author":"SS Farivar","year":"2007","unstructured":"Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007;5:54. https:\/\/doi.org\/10.1186\/1477-7525-5-54.","journal-title":"Health Qual Life Outcomes"},{"key":"3847_CR33","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67. https:\/\/doi.org\/10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"key":"3847_CR34","doi-asserted-by":"publisher","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest Package: Tests in Linear Mixed Effects Models. J Stat Softw. 2017;82. https:\/\/doi.org\/10.18637\/jss.v082.i13.","DOI":"10.18637\/jss.v082.i13"},{"key":"3847_CR35","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart F, Gautier B, Singh A, L\u00ea Cao K-A, mixOmics. An R package for \u2018omics feature selection and multiple data integration. PLoS Comput Biol. 2017;13:e1005752. https:\/\/doi.org\/10.1371\/journal.pcbi.1005752.","journal-title":"PLoS Comput Biol"},{"key":"3847_CR36","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.clnu.2024.05.046","volume":"43","author":"L Orioli","year":"2024","unstructured":"Orioli L, Samaras S, Sawadogo K, de Barsy M, Lause P, Deswysen Y, et al. Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity. Clin Nutr. 2024;43:1800\u20138. https:\/\/doi.org\/10.1016\/j.clnu.2024.05.046.","journal-title":"Clin Nutr"},{"key":"3847_CR37","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1210\/jc.2018-01056","volume":"103","author":"N Perakakis","year":"2018","unstructured":"Perakakis N, Mougios V, Fatouros I, Siopi A, Draganidis D, Peradze N, et al. Physiology of Activins\/Follistatins: Associations With Metabolic and Anthropometric Variables and Response to Exercise. J Clin Endocrinol Metab. 2018;103:3890\u20139. https:\/\/doi.org\/10.1210\/jc.2018-01056.","journal-title":"J Clin Endocrinol Metab"},{"key":"3847_CR38","doi-asserted-by":"publisher","unstructured":"Permpoon U, Moon J, Kim CY, Nam T-G. Glucocorticoid-Mediated Skeletal Muscle Atrophy: Molecular Mechanisms and Potential Therapeutic Targets. Int J Mol Sci. 2025;26. https:\/\/doi.org\/10.3390\/ijms26157616.","DOI":"10.3390\/ijms26157616"},{"key":"3847_CR39","first-page":"343","volume":"6","author":"KE Yarasheski","year":"2002","unstructured":"Yarasheski KE, Bhasin S, Sinha-Hikim I, Pak-Loduca J, Gonzalez-Cadavid NF. Serum myostatin-immunoreactive protein is increased in 60\u201392 year old women and men with muscle wasting. J Nutr Health Aging. 2002;6:343\u20138.","journal-title":"J Nutr Health Aging"},{"key":"3847_CR40","doi-asserted-by":"publisher","first-page":"e14500","DOI":"10.14814\/phy2.14500","volume":"8","author":"AG Dial","year":"2020","unstructured":"Dial AG, Monaco CMF, Grafham GK, Romanova N, Simpson JA, Tarnopolsky MA, et al. Muscle and serum myostatin expression in type 1 diabetes. Physiol Rep. 2020;8:e14500. https:\/\/doi.org\/10.14814\/phy2.14500.","journal-title":"Physiol Rep"},{"key":"3847_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","volume":"302","author":"KM Lakshman","year":"2009","unstructured":"Lakshman KM, Bhasin S, Corcoran C, Collins-Racie LA, Tchistiakova L, Forlow SB, et al. Measurement of myostatin concentrations in human serum: Circulating concentrations in young and older men and effects of testosterone administration. Mol Cell Endocrinol. 2009;302:26\u201332. https:\/\/doi.org\/10.1016\/j.mce.2008.12.019.","journal-title":"Mol Cell Endocrinol"},{"key":"3847_CR42","doi-asserted-by":"publisher","unstructured":"Ji Y, Li M, Chang M, Liu R, Qiu J, Wang K, et al. Inflammation: Roles in Skeletal Muscle Atrophy. Antioxid (Basel). 2022;11. https:\/\/doi.org\/10.3390\/antiox11091686.","DOI":"10.3390\/antiox11091686"},{"key":"3847_CR43","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.kint.2018.10.010","volume":"95","author":"D Verzola","year":"2019","unstructured":"Verzola D, Barisione C, Picciotto D, Garibotto G, Koppe L. Emerging role of myostatin and its inhibition in the setting of chronic kidney disease. Kidney Int. 2019;95:506\u201317. https:\/\/doi.org\/10.1016\/j.kint.2018.10.010.","journal-title":"Kidney Int"},{"key":"3847_CR44","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1096\/fj.10-176917","volume":"25","author":"L Zhang","year":"2011","unstructured":"Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011;25:1653\u201363. https:\/\/doi.org\/10.1096\/fj.10-176917.","journal-title":"FASEB J"},{"key":"3847_CR45","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.1007\/s12035-018-0997-9","volume":"55","author":"R Sachdev","year":"2018","unstructured":"Sachdev R, Kappes-Horn K, Paulsen L, Duernberger Y, Pleschka C, Denner P, et al. Endoplasmic Reticulum Stress Induces Myostatin High Molecular Weight Aggregates and Impairs Mature Myostatin Secretion. Mol Neurobiol. 2018;55:8355\u201373. https:\/\/doi.org\/10.1007\/s12035-018-0997-9.","journal-title":"Mol Neurobiol"},{"key":"3847_CR46","doi-asserted-by":"publisher","unstructured":"Alvarez AM, DeOcesano-Pereira C, Teixeira C, Moreira V. IL-1\u03b2 and TNF-\u03b1 Modulation of Proliferated and Committed Myoblasts: IL-6 and COX-2-Derived Prostaglandins as Key Actors in the Mechanisms Involved. Cells. 2020;9. https:\/\/doi.org\/10.3390\/cells9092005.","DOI":"10.3390\/cells9092005"},{"key":"3847_CR47","doi-asserted-by":"publisher","first-page":"R1592","DOI":"10.1152\/ajpregu.00247.2010","volume":"299","author":"DL Allen","year":"2010","unstructured":"Allen DL, Cleary AS, Hanson AM, Lindsay SF, Reed JM. CCAAT\/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1592\u2013601. https:\/\/doi.org\/10.1152\/ajpregu.00247.2010.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3847_CR48","doi-asserted-by":"publisher","first-page":"E1128","DOI":"10.1152\/ajpendo.2001.281.6.E1128","volume":"281","author":"K Ma","year":"2001","unstructured":"Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5\u2019-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab. 2001;281:E1128\u201336. https:\/\/doi.org\/10.1152\/ajpendo.2001.281.6.E1128.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3847_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.15252\/embj.201797883","volume":"37","author":"TR Cotton","year":"2018","unstructured":"Cotton TR, Fischer G, Wang X, McCoy JC, Czepnik M, Thompson TB, et al. Structure of the human myostatin precursor and determinants of growth factor latency. EMBO J. 2018;37:367\u201383. https:\/\/doi.org\/10.15252\/embj.201797883.","journal-title":"EMBO J"},{"key":"3847_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1210\/endrev\/bnab030","volume":"43","author":"BD Rodgers","year":"2022","unstructured":"Rodgers BD, Ward CW. Myostatin\/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs. Endocr Rev. 2022;43:329\u201365. https:\/\/doi.org\/10.1210\/endrev\/bnab030.","journal-title":"Endocr Rev"},{"key":"3847_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/RHU.0000000000001806","volume":"28","author":"CM de Sordi","year":"2022","unstructured":"de Sordi CM, Dos Reis-Neto ET, Keppeke GD, Shinjo SK, Sato EI. Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and Polymyositis. J Clin Rheumatol. 2022;28:33\u20137. https:\/\/doi.org\/10.1097\/RHU.0000000000001806.","journal-title":"J Clin Rheumatol"},{"key":"3847_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00401-005-1035-3","volume":"110","author":"S W\u00f3jcik","year":"2005","unstructured":"W\u00f3jcik S, Engel WK, McFerrin J, Askanas V. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers. Acta Neuropathol. 2005;110:173\u20137. https:\/\/doi.org\/10.1007\/s00401-005-1035-3.","journal-title":"Acta Neuropathol"},{"key":"3847_CR53","doi-asserted-by":"publisher","first-page":"364209","DOI":"10.1155\/2014\/364209","volume":"2014","author":"C Brandt","year":"2014","unstructured":"Brandt C, Pedersen M, Rinnov A, Andreasen AS, M\u00f8ller K, Hojman P, et al. Obesity and low-grade inflammation increase plasma follistatin-like 3 in humans. Mediators Inflamm. 2014;2014:364209. https:\/\/doi.org\/10.1155\/2014\/364209.","journal-title":"Mediators Inflamm"},{"key":"3847_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13395-015-0047-5","volume":"5","author":"HR Bergen","year":"2015","unstructured":"Bergen HR, Farr JN, Vanderboom PM, Atkinson EJ, White TA, Singh RJ, et al. Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skelet Muscle. 2015;5:21. https:\/\/doi.org\/10.1186\/s13395-015-0047-5.","journal-title":"Skelet Muscle"},{"key":"3847_CR55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12891-019-2650-9","volume":"20","author":"K Moriwaki","year":"2019","unstructured":"Moriwaki K, Matsumoto H, Tanishima S, Tanimura C, Osaki M, Nagashima H, et al. Association of serum bone- and muscle-derived factors with age, sex, body composition, and physical function in community-dwelling middle-aged and elderly adults: a cross-sectional study. BMC Musculoskelet Disord. 2019;20:276. https:\/\/doi.org\/10.1186\/s12891-019-2650-9.","journal-title":"BMC Musculoskelet Disord"},{"key":"3847_CR56","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/gerona\/glab146","volume":"77","author":"L Peng","year":"2022","unstructured":"Peng L, Gagliano-Juc\u00e1 T, Pencina KM, Krishnan S, Li Z, Tracy RP, et al. Age Trends in Growth and Differentiation Factor-11 and Myostatin Levels in Healthy Men, and Differential Response to Testosterone, Measured Using Liquid Chromatography-Tandem Mass Spectrometry. J Gerontol Biol Sci Med Sci. 2022;77:763\u20139. https:\/\/doi.org\/10.1093\/gerona\/glab146.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"3847_CR57","doi-asserted-by":"publisher","first-page":"G543","DOI":"10.1152\/ajpgi.00184.2021","volume":"321","author":"T Alexopoulos","year":"2021","unstructured":"Alexopoulos T, Vasilieva L, Kontogianni MD, Tenta R, Georgiou A, Stroumpouli E, et al. Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia. Am J Physiol Gastrointest Liver Physiol. 2021;321:G543\u201351. https:\/\/doi.org\/10.1152\/ajpgi.00184.2021.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3847_CR58","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s10753-015-0149-6","volume":"38","author":"T \u00c5kerfeldt","year":"2015","unstructured":"\u00c5kerfeldt T, Helmersson-Karlqvist J, Gunningberg L, Swenne CL, Larsson A. Postsurgical Acute Phase Reaction is Associated with Decreased Levels of Circulating Myostatin. Inflammation. 2015;38:1727\u201330. https:\/\/doi.org\/10.1007\/s10753-015-0149-6.","journal-title":"Inflammation"},{"key":"3847_CR59","doi-asserted-by":"publisher","unstructured":"Baczek J, Silkiewicz M, Wojszel ZB. Myostatin as a Biomarker of Muscle Wasting and other Pathologies-State of the Art and Knowledge Gaps. Nutrients. 2020;12. https:\/\/doi.org\/10.3390\/nu12082401.","DOI":"10.3390\/nu12082401"},{"key":"3847_CR60","doi-asserted-by":"publisher","first-page":"106785","DOI":"10.1016\/j.prostaglandins.2023.106785","volume":"169","author":"W Bielka","year":"2023","unstructured":"Bielka W, Przezak A, Pawlik A. Follistatin and follistatin-like 3 in metabolic disorders. Prostaglandins Other Lipid Mediat. 2023;169:106785. https:\/\/doi.org\/10.1016\/j.prostaglandins.2023.106785.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"3847_CR61","doi-asserted-by":"publisher","first-page":"953551","DOI":"10.3389\/fcell.2022.953551","volume":"10","author":"S Tian","year":"2022","unstructured":"Tian S, Xu X, Yang X, Fan L, Jiao Y, Zheng M, et al. Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers. Front Cell Dev Biol. 2022;10:953551. https:\/\/doi.org\/10.3389\/fcell.2022.953551.","journal-title":"Front Cell Dev Biol"},{"key":"3847_CR62","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00415-016-8379-6","volume":"264","author":"PM Burch","year":"2017","unstructured":"Burch PM, Pogoryelova O, Palandra J, Goldstein R, Bennett D, Fitz L, et al. Reduced serum myostatin concentrations associated with genetic muscle disease progression. J Neurol. 2017;264:541\u201353. https:\/\/doi.org\/10.1007\/s00415-016-8379-6.","journal-title":"J Neurol"},{"key":"3847_CR63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.nmd.2023.01.001","volume":"33","author":"U Moore","year":"2023","unstructured":"Moore U, Fern\u00e1ndez-Sim\u00f3n E, Schiava M, Cox D, Gordish-Dressman H, James MK, et al. Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy. Neuromuscul Disord. 2023;33:199\u2013207. https:\/\/doi.org\/10.1016\/j.nmd.2023.01.001.","journal-title":"Neuromuscul Disord"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03847-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03847-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:39:09Z","timestamp":1790120349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03847-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03847-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All relevant study documentation and amendments were approved by the independent Ethics Committee of the Institute of Rheumatology Prague with reference numbers 5675\/2015, 5688\/2015, 6487\/2020. The study was conducted following the principles outlined in the Declaration of Helsinki, the Guidelines of the International Council for Harmonisation (ICH) on Good Clinical Practise (GCP) Guideline E6 (R2) (EMA\/CPMP\/ICH\/ 135\/95) European Union (EU) Directive 95\/46\/EC, and other applicable regulatory requirements. Patients provided informed written consent before enrolment in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"174"}}